BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced the signing of an exclusive sublicense agreement with ...
BioTime, Inc. (NYSE MKT: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced the signing of an exclusive sublicense agreement and a ...
ALAMEDA, Calif.--(BUSINESS WIRE)--BioTime, Inc. (NYSE American: BTX), a clinical-stage biotechnology company focused on addressing degenerative diseases, announced today the submission of a design ...
Less than one year after BioTime subsidiary LifeMap Sciences spun off a mobile health company, LifeMap Solutions has embarked on a pilot study of its COPD Navigator with Mount Sinai Hospital, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback